Replies to post #240124 on Biotech Values

[DewDiligence]

FDA approves EYEN’s MydCombi drug/device spray on second review cycle—stock falls:

https://finance.yahoo.com/news/eyenovia-announces-fda-approval-mydcombi-120000042.html

I’m not sure how much demand there will be for this product. MydCombi is more convenient than the eye drops used pupil dilation, but it solves a problem most eye docs probably don’t consider to be a problem.